Work

Phase I Clinical Trial of BMS-247550, A Derivative of Epothilone B, Using Accelerated Titration 2B Design

Year: 2005

Type: article

Study design: Clinical Trial

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-05-0127

Authors: Shirish M. Gadgeel, Antoinette Wozniak, Ramesh R. Boinpally, Richard Wiegand, Lance K. Heilbrun, Vikas Jain, Ralph Parchment, Dimitrios Colevas, Marvin B. Cohen, Patricia M. LoRusso

Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, National Institutes of Health, National Cancer Institute, Bristol-Myers Squibb (United States)

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1895444557, G555835009, Early Clinical Trials of New Anti-Cancer Agents, CANCER CENTER SUPPORT GRANT

OpenAlex ID: W2022444430

FWCI: 5.931

Cites: 18

Cited by: 75

Related to: 10